Correlation Between GlaxoSmithKline PLC and Altice

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Altice at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Altice into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Altice France 55, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Altice and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Altice. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Altice.

Diversification Opportunities for GlaxoSmithKline PLC and Altice

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and Altice is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Altice France 55 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altice France 55 and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Altice. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altice France 55 has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Altice go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Altice

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Altice. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 1.5 times less risky than Altice. The stock trades about -0.23 of its potential returns per unit of risk. The Altice France 55 is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  7,798  in Altice France 55 on August 31, 2024 and sell it today you would earn a total of  140.00  from holding Altice France 55 or generate 1.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy77.27%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Altice France 55

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Altice France 55 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Altice France 55 are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Altice sustained solid returns over the last few months and may actually be approaching a breakup point.

GlaxoSmithKline PLC and Altice Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Altice

The main advantage of trading using opposite GlaxoSmithKline PLC and Altice positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Altice can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altice will offset losses from the drop in Altice's long position.
The idea behind GlaxoSmithKline PLC ADR and Altice France 55 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules